- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 473/36 - Sulfur atom
Patent holdings for IPC class C07D 473/36
Total number of patents in this class: 20
10-year publication summary
|
1
|
3
|
0
|
1
|
1
|
0
|
1
|
0
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2721 |
2 |
| Vironova Thionation AB | 5 |
2 |
| Changzhou Longthera Pharmaceuticals Inc | 2 |
2 |
| The Regents of the University of California | 20556 |
1 |
| Boehringer Ingelheim International GmbH | 4510 |
1 |
| Ecolab USA Inc. | 5732 |
1 |
| UCB Pharma S.A. | 224 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2971 |
1 |
| The University of Tokyo | 4328 |
1 |
| Vitae Pharmaceuticals, Inc. | 88 |
1 |
| Zenyaku Kogyo Kabushiki Kaisha | 19 |
1 |
| Agc, Inc. | 5320 |
1 |
| Dcam Pharma Inc | 1 |
1 |
| Livo (Shanghai) Pharmaceutical Co., Ltd | 1 |
1 |
| Micar Innovation Ltd. | 3 |
1 |
| Suzhou Splendus Therapeutics Limited | 1 |
1 |
| Gacter Inc. | 2 |
1 |
| Other owners | 0 |